Paragon novel vaccine - Immunethep
Alternative Names: Conjugated peptide based vaccine - Immunethep; Multivalent antibacterial vaccine - Immunethep; PNV - ImmunethepLatest Information Update: 29 Sep 2025
At a glance
- Originator Immunethep
- Class Bacterial vaccines; Conjugate vaccines; Peptide vaccines
- Mechanism of Action Bacterial protein inhibitors; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Preclinical Bacterial infections
Most Recent Events
- 16 Sep 2025 Paragon novel vaccine - Immunethep is available for licensing as of 16 Sep 2025. https://immunethep.com/
- 16 Sep 2025 Preclinical trials in Bacterial infections (Prevention) in USA (unspecified route) before September 2025 (Immunethep pipeline, September 2025)
- 25 Feb 2025 Early research in Escherichia coli infections (Prevention) in USA (unspecified route)